| Severe pulmonary toxicity associated with fludarabine and possible contribution of rituximab. | |
| | |
MedLine Citation:
|
PMID: 20357439 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Fludarabine is a nucleoside analogue used in the treatment of low-grade lymphoproliferative disorders and in conditioning regimens of non-myeloablative allogeneic stem cell transplantation. This is a relatively safe drug for clinical use but may cause side effects, some of which may be life-threatening. Here a case of severe pulmonary toxicity associated with fludarabine and a possible contribution of rituximab is presented and the literature reviewed. |
| | |
Authors:
|
U Disel; S Paydas; S Yavuz; E Karakoc |
Related Documents
:
|
10996239 - Isolated endobronchial atypical mycobacterium in a child: a case report and review of t... 1421719 - Partial anomalous pulmonary venous return showing anomalous venous return to the azygos... 1630989 - Primary pulmonary hypertension and functional hyposplenism. 16291829 - Pulmonary sporothrix schenckii infection in a hiv positive child. 12759629 - Pulmonary veno-occlusive disease after autologous bone marrow transplant in a child wit... 14708559 - Extrapulmonary presentation of asymptomatic pulmonary lymphangioleiomyomatosis. 20628329 - Traumatic pediatric pneumorachis: case report and review of the literature. 22405599 - Emergency testicular sperm extraction after scrotal trauma in a patient with a history... 7467979 - Suprasellar choristoma. |
Publication Detail:
|
Type: Case Reports; Journal Article Date: 2010-03-30 |
Journal Detail:
|
Title: Chemotherapy Volume: 56 ISSN: 1421-9794 ISO Abbreviation: Chemotherapy Publication Date: 2010 |
Date Detail:
|
Created Date: 2010-05-10 Completed Date: 2010-08-10 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 0144731 Medline TA: Chemotherapy Country: Switzerland |
Other Details:
|
Languages: eng Pagination: 89-93 Citation Subset: IM |
Copyright Information:
|
(c) 2010 S. Karger AG, Basel. |
Affiliation:
|
Department of Oncology and Intensive Care Unit, Cukurova University Faculty of Medicine, Adana, Turkey. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antibodies, Monoclonal
/
administration & dosage Antineoplastic Combined Chemotherapy Protocols / adverse effects*, therapeutic use Humans Lung Diseases / chemically induced*, physiopathology Lymphoma, Follicular / drug therapy Male Middle Aged Severity of Illness Index Vidarabine / administration & dosage, analogs & derivatives |
| Chemical | |
Reg. No./Substance:
|
0/Antibodies, Monoclonal; 0/rituximab; 21679-14-1/fludarabine; 5536-17-4/Vidarabine |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Association of a Genetic Variant in the ALOX5AP with Higher Risk of Ischemic Stroke: A Case-Control,...
Next Document: Phase II Trial of XELOX as First-Line Treatment for Patients with Advanced Gastric Cancer.